Tonix Pharma pops 8% on acquisition of R&D facility in Maryland
- BySeeking Alpha-
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tonix Pharmaceuticals Holding Corp (TNXP)
NASDAQ
Symbol | Exchange | Currency |
|---|
0.7160
-0.0105(-1.45%)
After Hours
0.7200
+0.0040(+0.5587%)
- Real-time Data
- Volume:4,871,052
- Bid/Ask:0.7200/0.7210
- Day's Range:0.7100 - 0.7300
TNXP Overview
- Prev. Close
- 0.7265
- Day's Range
- 0.71-0.73
- Revenue
- -
- Open
- 0.73
- 52 wk Range
- 0.51-2.11
- EPS
- -0.5
- Volume
- 4,871,052
- Market Cap
- 236.67M
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 10,541,197
- P/E Ratio
- -
- Beta
- 1.3
- 1-Year Change
- -44.5%
- Shares Outstanding
- 330,541,433
- Next Earnings Date
- Aug 16, 2021
What is your sentiment on Tonix Pharmaceuticals Holding Corp?
or
Market is currently closed. Voting is open during market hours.
Tonix Pharmaceuticals Holding Corp News
- Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
- ByBenzinga-
R&D Facility in Frederick, MD is Expected to Provide Internal Capacity to Discover and Develop Vaccines and Antiviral Drugs Against COVID-19, its Variants and Other Infectious...
- IDMC Recommends Tonix Pharma To Stop Enrollment In Fibromyalgia Trial; Shares Drop
- ByBenzinga-
Following an unblinded, pre-planned interim analysis by the Independent Data Monitoring Committee (IDMC), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) will stop enrollment in...
Tonix Pharmaceuticals Holding Corp Analysis
- Tonix Pharmaceuticals Announces Outcome of Interim Analysis of Phase 3 RALLY Study of TNX-102 SL for the Management of Fibromyalgia
- ByBenzinga-
RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14 in the First 50% of...
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Sell | Strong Sell | Strong Sell | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,694.50 | 2,706.10 | 2,685.10 | -21.0 | -0.77% | 1.28M | NASDAQ | |||
| 356.30 | 360.73 | 352.94 | -2.02 | -0.56% | 15.98M | NASDAQ | |||
| 28.05 | 28.40 | 28.01 | -0.24 | -0.85% | 37.50M | NYSE | |||
| 3.65 | 3.74 | 3.57 | +0.030 | +0.83% | 469.15K | NASDAQ | |||
| 8.82 | 8.87 | 7.97 | -0.41 | -4.44% | 1.25M | NYSE | |||
| 53.72 | 53.90 | 53.25 | +0.02 | +0.04% | 16.47M | NASDAQ | |||
| 9.56 | 9.63 | 9.15 | +0.21 | +2.25% | 286.86K | NASDAQ | |||
| 195.19 | 196.04 | 190.49 | -2.35 | -1.19% | 17.25M | NYSE | |||
| 0.587 | 0.00 | 0.00 | -0.0029 | -0.49% | 1.09M | NASDAQ | |||
| 1.89 | 1.93 | 1.82 | +0.060 | +3.28% | 124.03K | NASDAQ | |||
| 10.20 | 10.27 | 10.15 | -0.09 | -0.87% | 78.41K | NASDAQ | |||
| 2.99 | 3.72 | 2.80 | -0.910 | -23.33% | 41.29M | NASDAQ | |||
| 59.38 | 60.38 | 59.15 | -0.61 | -1.02% | 4.61M | NYSE | |||
| 194.99 | 196.30 | 192.63 | -1.63 | -0.83% | 18.35M | NASDAQ | |||
| 8.24 | 8.39 | 8.09 | -0.11 | -1.32% | 423.12K | NASDAQ |
Tonix Pharmaceuticals Holding Corp Company Profile
Tonix Pharmaceuticals Holding Corp Company Profile
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company’s lead vaccine candidate is TNX-1800, a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19. Its vaccines also comprise TNX-801, a live horsepox virus vaccine to protect against smallpox and monkeypox and serves as the vector platform; and TNX-2300 for the prevention of COVID-19. The company’s lead CNS candidate is TNX-102 SL, a sublingual tablet formulation of cyclobenzaprine for fibromyalgia, and for the treatment of agitation in Alzheimer’s disease, posttraumatic stress disorder (PTSD), and alcohol use disorder. Its products include TNX-1300 for the treatment of cocaine intoxication; TNX-601 CR for depression disorder, PTSD, and neurocognitive dysfunction from corticosteroids; and TNX-1900 for migraine and craniofacial pain treatment. Its preclinical pipeline includes TNX-1600 for PTSD, depression, and attention deficit hyperactivity disorder; TNX-1700 for gastric and pancreatic cancers; TNX-701 for radioprotection; TNX-1200, a smallpox vaccine; TNX-1500, a monoclonal antibody anti-CD40-L for organ transplant rejection autoimmunity; and TNX-2900, an intranasal potentiated oxytocin for the treatment of Prader-Willi syndrome. It also develops TNX-2100, a COVID-19 skin test. It has collaboration agreements with Southern Research Institute and the University of Alberta; and Massachusetts General Hospital. The company was incorporated in 2007 and is headquartered in Chatham, New Jersey.
Read More
- 2021-07-27 23:54:16https://ir.tonixpharma.com/press-releases/detail/1272/tonix-pharmaceuticals-announces-agreement-to-acquire
- 2021-07-26 15:34:11
what goes up must come down just need to know the fundamental and value in long run.- 2021-07-26 15:48:20Newton’s 3rd Law, and its opposite theorem, only strictly applies to objects affected by earths gravity- not the constant relative push and pull in our subjective view of the market.
- 2021-07-26 17:04:39
Even though I just sold all of my shares I have not totally given up on the company for it has several other therapies its working on.
- 2021-07-26 14:56:11
Why falling? - 2021-07-26 12:22:27today up or down? This looks really bad in the short term... I bought at 0.73 so losing money already
- 2021-07-26 10:39:42Why this fall?
- 2021-07-26 14:56:52Falling so that you BUY THE DIP
- 2021-07-25 20:57:34Good nees: https://www.proactiveinvestors.com/companies/amp/news/955128
- 2021-07-24 08:57:20omg losing money already... will this go up??
- 2021-07-23 10:44:26yeah tonix have💪💪
- 2021-07-21 22:12:16
they split 4 times since 2012...they were a giant...what happen then..lets move on now..daily n wkly oversold....good mkt cap more than 300 mil compared to CEMI .if cemi can do it ...why not tnxp as well :-) - 2021-07-15 13:15:17TNX - 102 COMING ?
- 2021-07-16 16:36:331.02 or 102? You gotta be joking LMAFO
- 2021-07-21 17:21:09Carlos GVes una patente xDD
- 2021-07-24 09:09:49Barren Wuffetsí gracias xdd
- 2021-07-12 17:47:34VERY ANNOYING STOCK. I will never buy it after I will close it with some profit
- 2021-07-09 08:49:57Time to boost towards 1,33+ NEWS https://www.reddit.com/r/TNXP/comments/ogkydy/tnxp_covid_vaccine_still_relevant/?utm_medium=android_app&utm_source=share
- 2021-07-02 21:17:41Next week is time to reverse the pull back, in the meantime in Europe RJFE will be rocketing!!!
- 2021-07-07 08:49:21you liaaaaaar... this isn't moving
- 2021-06-28 12:08:35this must be 2 already UUUUUUU...P
- 2021-06-25 20:04:24nice close
- 2021-06-25 17:03:59
Impressive, High volume but have been standing still whole day mostly.- 2021-06-25 19:49:21high pressure to sell and even higher to buy
- 2021-06-25 19:56:17Well .. Why sell if Russel comes? Only Shorts beein affected negative by that? But did seriously all shorters exit or what..
- 2021-06-28 18:13:41
dark pool
- 2021-06-25 09:16:15I bought at 0.58... I expect to buy again at 1.1-1.2 I hope its not too late for that
- 2021-06-24 22:20:24$10-20 easily when Covid factory built and vaccines on the line!
- 2021-06-25 08:37:14in years?
- 2021-06-25 11:52:45obviously not in months and NOT this year anyway
- 2021-06-25 15:12:48Who knows, just look at how all these pharma companies have rocketed, Ocugen, Entera, not to mention Moderna ans likes. Based on that 10 is just a blink of an eye if factory production starts.
- 2021-06-23 17:30:48qualcuno che conosce la storia del titolo, può spiegarmi il perché di quel valore a maggio 2013?
- 2021-06-14 11:01:11this will jump after 28th June (Russel 300 listed) and skyrocket in August (Fibro Ph3 approval).
- 2021-06-14 11:01:32Russel 3000
- 2021-06-08 15:24:01
What is the Expectation of this stock- 2021-06-10 01:27:16I expect it to make me rich.
- 2021-06-14 14:01:275-6
- 2021-06-17 08:31:56Piter Maxi hope so...I got in at 0.50
- 2021-06-06 16:11:48Last friday Tonix was included in RUSSEL 3000 ( list with companies with 2B$ avg capitalization). This will run strong IMO.
- 2021-06-07 17:34:04not enough... need results
- 2021-06-07 19:27:56I do agree with your thoughts on the stock. Must review the income statement, statement of retained earnings, and balance sheet and 10-K statements again.
- 2021-06-08 06:51:53TNX 102SL Ph3 approval result for August. Russel is already considering this future turnover in their list. 10B$ market with 57% unsatisfied patients. last fibro drug launch was in 2009. TNX 1800 is a plus. Big tutes knows and are loading heavly.
- 2021-06-04 11:58:23just the matter of time a this company will be huge, now time to buy more and more in my opinion.
- 2021-05-17 22:45:06
ExodusPoint Capital Management, LP bought 595,459 shares (update 2021-05-17)!!!!Vanguard Group Inc has 14,678,162 Mio. shares!!! (update 2021-05-14) - 2021-04-29 12:31:30starting feel like someone poured sand on the skids.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.